Janis M. Taube

5 ta ish

Bloomberg (United States)

1. PD-1 Blockade in Tumors with Mismatch-Repair Deficiency

   Dung T. Le, Jennifer N. Uram, Hao Wang +32

   Maqola20155 iqtibos

   ABIABI:AkademIndex/2026.other.630148

2. Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer

   Suzanne L. Topalian, F. Stephen Hodi, Julie R. Brahmer +27

   MaqolaOAOchiq kirish20123 iqtibos

   ABIABI:AkademIndex/2026.other.132162

3. Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade

   Dung T. Le, Jennifer N. Durham, Kellie N. Smith +43

   MaqolaOAOchiq kirish20172 iqtibos

   ABIABI:AkademIndex/2026.other.121349

4. Implications of the tumor immune microenvironment for staging and therapeutics

   Janis M. Taube, Jérôme Galon, Lynette M. Sholl +8

   Sharh maqola20172 iqtibos

   ABIABI:AkademIndex/2026.other.267815

5. The Vigorous Immune Microenvironment of Microsatellite Instable Colon Cancer Is Balanced by Multiple Counter-Inhibitory Checkpoints

   Nicolás J. Llosa, Michael Cruise, Ada Tam +15

   Maqola20142 iqtibos

   ABIABI:AkademIndex/2026.other.322543